Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $19.10 USD
Change Today +0.10 / 0.53%
Volume 187.1K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric E. Hedrick M.D.

Former Chief Medical Officer, Epizyme, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

49--
As of Fiscal Year 2013

Background*

Dr. Eric E. Hedrick, M.D. served as the Chief Medical Officer of Epizyme, Inc. from May 2012 to October 31, 2014. Dr. Hedrick served as an Interim Chief Medical Officer of Pharmacyclics Inc. since May 2011 and served as its Vice President of Oncology Development from August 2010 to April 2012. From October 2009 to August 2010, Dr. Hedrick was an independent drug development consultant, including consulting with Pharmacyclics on the development of PCI-32765. From November ...

Read Full Background

Corporate Headquarters*

400 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-229-5872
Fax: 617-349-0707

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Boston University
MD
University of Maryland School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EPZM:US $19.10 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr11.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIZYME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.